Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. A
stocks logo

A

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2026Q2
FY2026Q3
1.81B
+7.6%
1.372
+4.7%
1.76B
+5.76%
1.394
+6.4%
1.82B
+4.96%
1.488
+8.58%
Estimates Revision
The market is revising Upward the revenue expectations for Agilent Technologies, Inc. (A) for FY2026, with the revenue forecasts being adjusted by 0.81% over the past three months. During the same period, the stock price has changed by 13.34%.
Revenue Estimates for FY2026
Revise Upward
up Image
+0.81%
In Past 3 Month
EPS Estimates for FY2026
Revise Downward
down Image
-1.19%
In Past 3 Month
Stock Price
Go Up
up Image
+13.34%
In Past 3 Month
Wall Street analysts forecast A stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for A is 167.92 USD with a low forecast of 130.00 USD and a high forecast of 185.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
Wall Street analysts forecast A stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for A is 167.92 USD with a low forecast of 130.00 USD and a high forecast of 185.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
4 Hold
0 Sell
Moderate Buy
Current: 139.680
sliders
Low
130.00
Averages
167.92
High
185.00
Current: 139.680
sliders
Low
130.00
Averages
167.92
High
185.00
Goldman Sachs
Buy
initiated
$170
2025-12-09
New
Reason
Goldman Sachs
Price Target
$170
2025-12-09
New
initiated
Buy
Reason
Goldman Sachs initiated coverage of Agilent with a Buy rating and $170 price target. The firm rolled out coverage of the large cap life science tools stocks with the expectation that they will eventually return to their historic market growth rate of 5%. However, some end markets will recover faster than others, the analyst tells investors in a research note. Goldman is taking a more cautious view on the timing of the drug discovery end market recovery and believes the recent uptick in biotech funding is largely focused on later stage assets. It also takes a more cautious stance on U.S. academic and government spending. The firm says investors need to be selective, and likes exposure to commercialized biopharma manufacturing, later stage research, and industrials.
Morgan Stanley
initiated
$180
2025-12-02
Reason
Morgan Stanley
Price Target
$180
2025-12-02
initiated
Reason
As previously reported, Morgan Stanley initiated coverage of Agilent (A) with an Overweight rating and $180 price target. Life Science Tools and Diagnostics end market bright spots are beginning to emerge and the firm sees "plenty of catalysts" in the pipeline across its coverage, adding that it sees "lots to like in the space entering 2026." However, a recent industry valuation spike in the second half of the year leaves multiples in "a fair place," so the firm starts the group with an In-Line industry view, the analyst tells investors. Among the group, the analyst identifies Danaher (DHR) as Top Pick. This note corrects a prior version with an incorrect price target for Agilent.
Baird
Catherine Ramsey Schulte
Outperform
maintain
$142 -> $165
2025-11-25
Reason
Baird
Catherine Ramsey Schulte
Price Target
$142 -> $165
2025-11-25
maintain
Outperform
Reason
Baird analyst Catherine Ramsey Schulte raised the firm's price target on Agilent to $165 from $142 and keeps an Outperform rating on the shares. The firm updated its model following solid Q4 results which posted a revenue beat and a 2026 inline revenue outlook.
UBS
Buy
maintain
$170 -> $180
2025-11-25
Reason
UBS
Price Target
$170 -> $180
2025-11-25
maintain
Buy
Reason
UBS raised the firm's price target on Agilent to $180 from $170 and keeps a Buy rating on the shares. The firm updated its model following its Q4 beat and in-line 2026 guidance.
TD Cowen
Dan Brennan
Buy
maintain
$162 -> $170
2025-11-25
Reason
TD Cowen
Dan Brennan
Price Target
$162 -> $170
2025-11-25
maintain
Buy
Reason
TD Cowen analyst Dan Brennan raised the firm's price target on Agilent to $170 from $162 and keeps a Buy rating on the shares. The firm noted organic growth was strong and broad based and ahead of consensus but EBIT margins missed limiting upside to earnings.
Barclays
Equal Weight
maintain
$145 -> $165
2025-11-25
Reason
Barclays
Price Target
$145 -> $165
2025-11-25
maintain
Equal Weight
Reason
Barclays raised the firm's price target on Agilent to $165 from $145 and keeps an Equal Weight rating on the shares. The company reported a solid quarter "with little to pick on," the analyst tells investors in a research note.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Agilent Technologies Inc (A.N) is 24.02, compared to its 5-year average forward P/E of 25.64. For a more detailed relative valuation and DCF analysis to assess Agilent Technologies Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
25.64
Current PE
24.02
Overvalued PE
29.89
Undervalued PE
21.39

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
20.81
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
23.94
Undervalued EV/EBITDA
17.69

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
5.84
Current PS
0.00
Overvalued PS
6.60
Undervalued PS
5.08
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

A News & Events

Events Timeline

(ET)
2025-12-01
16:30:00
Morgan Stanley Initiates Overweight Rating on Agilent (A) with $270 Price Target
select
2025-11-24 (ET)
2025-11-24
16:13:19
Agilent projects FY26 EPS between $5.86 and $6.00, while consensus estimates at $6.02.
select
2025-11-24
16:12:38
Agilent projects Q1 EPS between $1.35 and $1.38, below consensus of $1.43
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.5
12-11CNBC
Jim Cramer's 10 Key Stock Market Insights for Thursday

  • Disney's Investment in OpenAI: Disney announced a $1 billion equity investment in OpenAI, allowing users to create videos with its animated characters on the Sora platform, which includes over 200 characters from Disney, Marvel, Pixar, and Star Wars.

  • Market Reactions to Federal Reserve Decisions: The S&P 500 is expected to open lower following the Federal Reserve's recent interest rate cut, with Oracle shares dropping over 13% after disappointing earnings, while Adobe and Synopsys received positive outlooks from analysts.

  • Eli Lilly's Obesity Treatment Success: Eli Lilly's experimental obesity treatment, Retatrutide, showed significant weight loss and reduced knee arthritis pain in trials, contributing to a slight increase in its stock price.

  • Oil Market Adjustments: Bank of America downgraded several oil stocks, including Valero, citing potential declines in crude market support, while TD Cowen raised its price target for SLB, indicating expected stability in oil field services.

[object Object]
Preview
6.0
12-09Yahoo Finance
Goldman Sachs Initiates Coverage on Life Sciences Tools, Assigns Buy Ratings to Three Stocks

  • Goldman Sachs Coverage: Goldman Sachs has initiated coverage of the Life Sciences Tools sector, projecting a return to a historic market growth rate of approximately 5% as certain end markets recover, while highlighting the selective performance of companies based on their market exposure.

  • Stock Ratings: The firm has rated Thermo Fisher Scientific, Agilent Technologies, and Danaher as Buy, citing their strong positioning in improving market segments, while Bruker has been rated Sell due to its reliance on early-stage discovery and U.S. academic funding.

  • Market Sentiment: Recent improvements in sentiment are attributed to better biotech funding data and a rotation back into healthcare, although the uneven performance of tools companies has been influenced by factors such as Covid-related revenue declines and funding uncertainties.

  • China Market Outlook: The outlook for China is mixed, with improvements noted in biopharma and industrial sectors, but ongoing challenges remain in diagnostics, reflecting the varied recovery across different market segments.

[object Object]
Preview
4.0
12-06NASDAQ.COM
Agilent Technologies (A) Price Target Raised by 10.53% to $170.51

  • Price Target Update: The average one-year price target for Agilent Technologies (NYSE:A) has been revised to $170.51 per share, reflecting a 10.53% increase from the previous estimate of $154.27, with a range between $151.36 and $194.25.

  • Fund Sentiment: There are 1,846 funds reporting positions in Agilent Technologies, showing a decrease of 2.02% in ownership over the last quarter, while the average portfolio weight dedicated to the stock has increased by 2.99%.

  • Shareholder Activity: Massachusetts Financial Services and Wellington Management Group have both decreased their holdings in Agilent, while T. Rowe Price and Vanguard 500 Index Fund have made slight adjustments to their allocations.

  • Market Outlook: The put/call ratio for Agilent is at 0.96, indicating a bullish sentiment among investors, suggesting optimism about the stock's future performance.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Agilent Technologies Inc (A) stock price today?

The current price of A is 139.68 USD — it has decreased -2.23 % in the last trading day.

arrow icon

What is Agilent Technologies Inc (A)'s business?

Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.

arrow icon

What is the price predicton of A Stock?

Wall Street analysts forecast A stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for A is 167.92 USD with a low forecast of 130.00 USD and a high forecast of 185.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Agilent Technologies Inc (A)'s revenue for the last quarter?

Agilent Technologies Inc revenue for the last quarter amounts to 1.86B USD, increased 9.41 % YoY.

arrow icon

What is Agilent Technologies Inc (A)'s earnings per share (EPS) for the last quarter?

Agilent Technologies Inc. EPS for the last quarter amounts to 1.53 USD, increased 24.39 % YoY.

arrow icon

What changes have occurred in the market's expectations for Agilent Technologies Inc (A)'s fundamentals?

The market is revising Upward the revenue expectations for Agilent Technologies, Inc. (A) for FY2026, with the revenue forecasts being adjusted by 0.81% over the past three months. During the same period, the stock price has changed by 13.34%.
arrow icon

How many employees does Agilent Technologies Inc (A). have?

Agilent Technologies Inc (A) has 17900 emplpoyees as of December 13 2025.

arrow icon

What is Agilent Technologies Inc (A) market cap?

Today A has the market capitalization of 39.54B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free